All Stories

  1. Clinical trials: beyond efficiency – why are we flying blind?
  2. Corrigendum: Core competencies for pharmaceutical physicians and drug development scientists
  3. The Ethics and Economics of Pharmaceutical Pricing
  4. Application of systems thinking and systems engineering principles to enhance safety and pharmacovigilance through real-time informatics
  5. The Synergy of the Whole: Building a Global System for Clinical Trials to Accelerate Medicines Development
  6. Getting Past Protectionism: Is It Time to Take off the Training Wheels?
  7. Core competencies for pharmaceutical physicians and drug development scientists
  8. “Rethinking Research Ethics,” Again: Casuistry, Phronesis, and the Continuing Challenges of Human Research
  9. Consent for genetic research in the Framingham Heart Study
  10. Policies and Management of Conflicts of Interest Within Medical Research Institutional Review Boards: Results of a National Study
  11. Ethical Issues in Translational Research and Clinical Investigation
  12. Opinions of IRB Members and Chairs Regarding Investigators' Relationships with Industry
  13. Tipping Point, Over the Top, or Just Noncompliance as Usual?
  14. Financial Relationships between Institutional Review Board Members and Industry
  15. Healthcare Research: Can Patients Trust Physician Scientists?
  16. Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group
  17. Cooperative Research Ethics Review Boards: A Win-Win Solution?
  18. Pharma PR or Medical Education?
  19. FDA and the Life-Sciences Industry: Business as Usual?
  20. Ethics, Science, and Oversight of Critical Care Research
  21. Drug-Testing Research in High School Students: Is There a Will or a Way?
  22. Imagination and attention: protecting participants in psychopharmacological research
  23. Changing the Paradigm: New Directions in Federal Oversight of Human Research
  24. Beyond Compliance... Is It Too Much to Ask?
  25. Ethical Issues in Antiepileptic Trials: Old Issues in a New World
  26. Research ethics and the intensive care unit: Getting behind the wheel
  27. Research Involving Human Subjects in Developing Countries
  28. Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Clinical Trial
  29. Statement of Greg Koski, Ph.D., M.D., for the Hearing on Human Subjects Protections in VA Medical Research before the Subcommittee on Oversight and Investigations, Committee on Veterans Affairs, U.S. House of Representatives
  30. Risks, Benefits, and Conflicts of Interest in Human Research: Ethical Evolution in the Changing World of Science
  31. To Protect Those Who Serve
  32. Internal mammary artery spasm: Is calcium the culprit?
  33. Resolving Beecher's Paradox: Getting beyond IRB reform
  34. Calcium Administration Augments Pancreatic Injury and Ectopic Trypsinogen Activation after Temporary Systemic Hypotension in Rats
  35. Norepinephrine Infusion Following Cardiopulmonary Bypass: Effect of Infusion Site
  36. Intrathecal Magnesium Sulfate Protects the Spinal Cord from Ischemic Injury during Thoracic Aortic Cross-clamping
  37. Intrathecal Magnesium Sulfate Protects the Spinal Cord from Ischemic Injury during Thoracic Aortic Cross-clamping
  38. Off the beaten path
  39. Effect of chronic ethanol on calcium currents and calcium uptake in undifferetiated PC12 cells
  40. Indcations for the use of pacing pulmonary artery catheters in cardiac surgery
  41. Risk Factors for Pancreatic Cellular Injury after Cardiopulmonary Bypass
  42. Inhibition by Ethanol of45Ca2+Uptake in PC12 Pheochromocytoma Cells.
  43. Fentanyl and Sufentanil Anesthesia Revisited
  44. Fentanyl and Sufentanil Anesthesia Revisited
  45. Acute reduction of extracellular sodium differentially affects receptor-mediated and K+-induced calcium uptake in PC12 pheochromocytoma cells
  46. Inadvertent Passage of a Pulmonary Artery Catheter from the Superior Vena Cava Through the Left Atrium and Left Ventricle into the Aorta
  47. Con: Calcium salts are contraindicated in weaning of patients from cardiopulmonary bypass after coronary artery surgery
  48. Effect of Hypothermic Hemodilutional Cardiopulmonary Bypass on Plasma Sufentanil and Catecholamine Concentrations in Humans
  49. Understanding Public Attitudes to Clinical Xenotransplantation
  50. Systems-Thinking and Clinical Research
  51. Renegotiating the Grand Bargain: Balancing Prices, Profits, People, and Principles
  52. The Triple Helix: University, Government and Industry Relationships in the Life Sciences